2024-512617-41-00招募中1 期
A Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics and Safety of ANT3310 Combined with Meropenem Administered as a Single Intravenous Infusion to Adult Subjects with Renal Function Impairment
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Antabio
- 入组人数
- 48
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical department
Scientific
Antabio
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study to test different doses of BI 764532 combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3.Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3.JPRN-jRCT2031220716Mori Hiroko4
进行中（未招募）
1 期
Safety and pharmacokinetics of ceftolozane/tazobactam in pediatric participants with nosocomial pneumoniaosocomial pneumoniaMedDRA version: 21.1Level: LLTClassification code 10052596Term: Nosocomial pneumoniaSystem Organ Class: 100000004862EUCTR2018-004704-19-EEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc40
招募中
1 期
Safety and pharmacokinetics of ceftolozane/tazobactam in pediatric participants with nosocomial pneumoniaosocomial infection, PneumoniaMedDRA version: 21.1Level: LLTClassification code: 10052596Term: Nosocomial pneumonia Class: 10021881CTIS2022-501110-56-00Merck Sharp & Dohme LLC67
进行中（未招募）
1 期
Safety and pharmacokinetics of ceftolozane/tazobactam in pediatric participants with nosocomial pneumoniaosocomial pneumoniaMedDRA version: 21.1Level: LLTClassification code 10052596Term: Nosocomial pneumoniaSystem Organ Class: 100000004862EUCTR2018-004704-19-GRMerck Sharp & Dohme LLC, a subsidiary of Merck & Co.,Inc40
进行中（未招募）
1 期
Safety and pharmacokinetics of ceftolozane/tazobactam in pediatric participants with nosocomial pneumoniaosocomial pneumoniaMedDRA version: 20.1Level: LLTClassification code 10052596Term: Nosocomial pneumoniaSystem Organ Class: 100000004862EUCTR2018-004704-19-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc40